References
- Piel FB, Patil AP, Howes RE, et al. Global epidemiology of sickle haemoglobin in neonates: a contemporary geostatistical model-based map and population estimates. Lancet. 2013;381(9861):142–151.
- Ware RE, de Montalembert M, Tshilolo L, et al. Sickle cell disease. Lancet. 2017;390(10091):311–323.
- Grosse SD, Odame I, Atrash HK, et al. Sickle cell disease in Africa: a neglected cause of early childhood mortality. Am J Prev Med. 2011;41(6 Suppl 4):S398–S405.
- Couque N, Girard D, Ducrocq R, et al. Improvement of medical care in a cohort of newborns with sickle-cell disease in North Paris: impact of national guidelines. Br J Haematol. 2016;173(6):927–937.
- Lanzkron S, Carroll CP, Haywood C. Jr. Mortality rates and age at death from sickle cell disease: U.S., 1979–2005. Public Health Rep. 2013;128(2):110–116.
- Quinn CT, Rogers ZR, McCavit TL, et al. Improved survival of children and adolescents with sickle cell disease. Blood. 2010;115(17):3447–3452.
- Lopes de Castro Lobo C, Pinto JFC, Nascimento EM, et al. The effect of hydroxcarbamide therapy on survival of children with sickle cell disease. Br J Haematol. 2013;161(6):852–860.
- Voskaridou E, Christoulas D, Bilalis A, et al. The effect of prolonged administration of hydroxyurea on morbidity and mortality in adult patients with sickle cell syndromes: results of a 17-year, single-center trial (LaSHS). Blood. 2010;115(12):2354–2363.
- King LG, Bortolusso-Ali S, Cunningham-Myrie CA, et al. Impact of a comprehensive sickle cell center on early childhood mortality in a developing country: the Jamaican experience. J Pediatr. 2015;167(3):702–705.e1.
- Diniz KKS, Pagano AS, Fernandes APPC, et al. Knowledge of professional healthcare providers about sickle cell disease: impact of a distance education course. Hematol Transfus Cell Ther. 2019;41(1):62–68.
- Kaur M, Brown M, Love TW, et al. Understanding sickle cell disease: impact of surveillance and gaps in knowledge. Blood Adv. 2020;4(3):496–498.
- Blinder MA, Vekeman F, Sasane M, et al. Age-related treatment patterns in sickle cell disease patients and the associated sickle cell complications and healthcare costs. Pediatr Blood Cancer. 2013;60(5):828–835.
- Binding A, Ward R, Phua C, et al. An innovative short-stay health care model for treatment of uncomplicated vaso-occlusive crisis in adult sickle cell disease patients in Canada to reduce emergency department utilization. CJEM. 2019;21(1):55–62.
- Hamm J, Hilliard L, Howard T, et al. Maintaining high level of care at satellite sickle cell clinics. J Health Care Poor Underserved. 2016;27(1):280–292.